DWA
SURF

Dorsey Wright & Associates’s Surface Oncology, Inc. Common Stock SURF Stock Holding History

Dorsey Wright & Associates’s Portfolio SURF Stock Details SURF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,667
Closed -$15K – 387
2020
Q4 		$15K Buy
1,667
+417
+33% +$3.62K ﹤0.01% 226
2020
Q3 		$9K Buy
+1,250
New +$7.58K ﹤0.01% 221

Other funds holding SURF

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
AVAI
Atlas Venture Associates IX Boston, Massachusetts $11.8M AUM 58.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Dorsey Wright & Associates's SURF Position: Q1 2021 in Review

Dorsey Wright & Associates sold out of Surface Oncology, Inc. Common Stock (SURF) in Q1 2021, closing a stake of 1,667 shares — an estimated $15K sold.

Dorsey Wright & Associates first reported a position in SURF in Q3 2020 and held it in 2 quarters. The position peaked at $15K in Q4 2020. 90 funds tracked by Wall St. Rank hold SURF as of Q1 2021.

  • Dorsey Wright & Associates reported no remaining Surface Oncology, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Dorsey Wright & Associates sold 1,667 Surface Oncology, Inc. Common Stock shares in Q1 2021, an estimated $15K.
  • Dorsey Wright & Associates first reported a position in Surface Oncology, Inc. Common Stock in Q3 2020 and held it in 2 quarters.
  • Dorsey Wright & Associates's Surface Oncology, Inc. Common Stock position peaked at $15K in Q4 2020.
  • 90 funds tracked by Wall St. Rank held Surface Oncology, Inc. Common Stock as of Q1 2021.

Based on Dorsey Wright & Associates's 13F filing for Q1 2021, filed 27 Apr 2021.